- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03995238
Optimizing Gait Rehabilitation for Veterans With Non-traumatic Lower Limb Amputation (GEM)
April 6, 2026 updated by: VA Office of Research and Development
Optimizing Gait Rehabilitation for Veterans With Non-Traumatic Lower Limb Amputation
The population of older Veterans with non-traumatic lower limb amputation is growing.
Following lower limb amputation, asymmetrical movements persist during walking and likely contribute to disabling sequelae including secondary pain conditions, poor gait efficiency, impaired physical function, and compromised skin integrity of the residual limb.
This study seeks to address chronic gait asymmetry by evaluating the efficacy of two error-manipulation gait training programs to improve gait symmetry for Veterans with non-traumatic lower limb amputation.
Additional this study will evaluate the potential of error-manipulation training programs to improve secondary measures of disability and residual limb skin health.
Ultimately, this study aims to improve conventional prosthetic rehabilitation for Veterans with non-traumatic amputation through gait training programs based in motor learning principles, resulting in improved gait symmetry and lower incidence of long-term disability after non-traumatic lower limb amputation.
Study Overview
Status
Recruiting
Detailed Description
The focus of this study is to improve walking symmetry in order to optimize walking ability and reduce disability for Veterans with non-traumatic lower limb amputation (LLA).
Over 80% of current LLAs are non-traumatic, resulting from complications of pathologies, such as diabetes mellitus and peripheral artery disease.
Despite current declines in total amputation rate among Veterans, the population with non-traumatic LLA is growing.
For example, from 2000 to 2004 the relative amputation rate decreased by 34%.
However, due to an increase in the number of Veterans with diabetes during the same period, the population of Veterans with diabetes and initial LLA increased by 23%.
Following LLA, excessive gait asymmetry is common.
Asymmetric gait characteristics are of critical importance as excessive asymmetry may increase the severity of disability experienced by people with non-traumatic LLA and contribute to secondary pain conditions (low back pain and osteoarthritis), poor gait efficiency, declines in physical performance, and compromised skin integrity of the residual limb.
Compared to individuals with traumatic LLA, the poor gait performance of those with non-traumatic LLA is further compounded by older age, lower premorbid function, presence of comorbidities, frequent wound development, and delayed healing in the residual limb.
While improving gait symmetry is a goal of conventional prosthetic rehabilitation, persistence of gait asymmetry for years after LLA highlights the ineffectiveness of current rehabilitation practices in achieving this goal.
As a means of improving gait symmetry, this study aims to determine the efficacy of error-manipulation gait training using two approaches (error-augmentation and error-correction) compared to current standard-of-care in a three-arm randomized controlled trial.
Error-manipulation gait training intervention will be delivered in eight training sessions (2x/week, 4 weeks) with 54 Veterans (18 per intervention group, 18 in control group) who have non-traumatic, unilateral, transtibial LLA.
It is unclear which, if either, form of error-manipulation gait training is efficacious for improving persistent gait symmetry in Veterans with non-traumatic LLA.
Error-augmentation gait training is a promising and novel intervention that involves exaggerating an existing movement error to force the neuromuscular system to correct the error.
While this form of gait training improved gait symmetry in small studies of individuals with chronic stroke or traumatic amputation, it has yet to be evaluated in older Veterans with non-traumatic LLA.
In contrast, error-correction training involves reducing movement errors by overcorrecting for asymmetry.
Both error-augmentation and error-correction gait training are based upon motor learning principles of distributed practice, task specificity, and feedback.
Each of these error-manipulation interventions have potential advantages over traditional gait training following LLA which involves repeated bouts of walking with minimal feedback on movement quality and is often unsupervised.
Therefore, the primary aim of this study is to determine the efficacy of error-manipulation gait training to improve gait symmetry.
A secondary aim is to evaluate signals of efficacy for improved secondary measures of physical function.
Lastly, this study will explore changes to residual limb skin health and prosthesis socket fit following error-manipulation gait training.
The unique use of motor learning principles in error-manipulation gait training to improve gait symmetry addresses the problem of chronic gait asymmetry following non-traumatic LLA.
The results of this study will advance rehabilitation knowledge and provide necessary evidence for the clinical translation of gait training protocols based in motor learning principles for the at-risk population of Veterans with non-traumatic LLA.
Study Type
Interventional
Enrollment (Estimated)
54
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Cory L Christiansen, PhD
- Phone Number: (303) 724-9101
- Email: Cory.Christiansen@va.gov
Study Contact Backup
- Name: Ryan Stephenson, DO
- Phone Number: (303) 399-8020
- Email: ryan.stephenson@va.gov
Study Locations
-
-
Colorado
-
Aurora, Colorado, United States, 80045-7211
- Recruiting
- Rocky Mountain Regional VA Medical Center, Aurora, CO
-
Contact:
- Thomas Fields, DPT
- Phone Number: (720) 723-3372
- Email: thomas.fields@va.gov
-
Principal Investigator:
- Cory L. Christiansen, PhD
-
Contact:
- Ryan Stephenson, DO
- Phone Number: 303-399-8020
- Email: ryan.stephenson@va.gov
-
-
Virginia
-
Richmond, Virginia, United States, 23249
- Recruiting
- Hunter Holmes McGuire VA Medical Center, Richmond, VA
-
Contact:
- John Hermanson, MD
- Email: john.hermanson@va.gov
-
Contact:
- Benjamin Darter, DPT
- Email: benjamin.darter@va.gov
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 89 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Unilateral, non-traumatic, transtibial amputation
- Diabetes mellitus and/or peripheral artery disease
- Able to ambulate in the community without assistive device
- Step length asymmetry during walking (>1.0 asymmetry index.)
- 6 months since amputation
Exclusion Criteria:
- Unstable heart condition
- Including unstable angina, uncontrolled cardiac dysrhythmia, acute myocarditis, hypertension, and acute pericarditis
- Acute systemic infection
- Active cancer treatment
- Traumatic or cancer related amputation etiology
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Error-augmentation training
A 4-week, 8 session, treadmill-based gait training program, with error-augmentation of step asymmetry delivered on a split-belt treadmill.
Each training session will adhere to the same schedule.
During the training blocks on the treadmill, the belt under the limb with the shorter step length will be set at 3/4 of the pre-intervention over-ground self-selected walking speed while the belt under the limb with the longer step length will be set to 1/2 of the fast belt speed (2:1 ratio between belts).
|
Split-belt treadmill training to enhance between-limb asymmetry during treadmill walking, which is intended to force compensation and correction of step asymmetry during treadmill walking.
The error-augmentation gait training program is delivered in 8 sessions over 4 weeks.
|
|
Experimental: Error-correction training
A 4-week, 8 session, treadmill-based gait training program, with error-correction of step asymmetry delivered with an auditory metronome signal while walking on a treadmill.
During each training block, the metronome will be set to overcorrect stance time asymmetry through use of asymmetrical metronome tones, 2:1 ratio.
|
Metronome will be set to cue participants to overcorrect between-limb step asymmetry during treadmill walking, through use of asymmetrical metronome tones in a 2:1 ratio.
The error-correction gait training program is delivered in 8 sessions over 4 weeks.
|
|
Active Comparator: Supervised waking
A 4-week, 8 session, treadmill-based supervised walking program.
The active comparator group will participate in a supervised treadmill walking program of the same frequency and duration, to the two experimental groups.
|
An active comparator intervention, in which a supervised treadmill walking program is delivered without attempt to correct step asymmetry.
The supervised walking program is delivered in 8 sessions over 4 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Step Length Symmetry
Time Frame: Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end.
|
Measurement of step length symmetry by overground walking on GAITRite mat and kinetic and kinematic measurements using 3-D motion capture system.
|
Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Six-minute walk test
Time Frame: Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end.
|
Physical function test measuring the total distance walked in a span of six minutes.
|
Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end.
|
|
Free-living daily step count
Time Frame: Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end.
|
Accelerometer-based measurement of free-living daily step count
|
Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end.
|
|
World Health Organization Disability Assessment Scale 2.0
Time Frame: Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end.
|
Self-reported assessment of disability using a scale from 0 to 100, with 0 representing no disability, and 100 representing full disability.
|
Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Transcutaneous oximetry
Time Frame: Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end.
|
Measurement of residual limb integumentary health.
|
Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end.
|
|
Socket Comfort Score
Time Frame: Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end.
|
Measurement of limb-socket interface by rating of prosthetic socket fit using a scale from 0 to 10, with 0 representing the most uncomfortable socket fit and 10 representing the most comfortable socket fit.
|
Change from baseline (pre-intervention) to intervention end, persisting at 12 weeks after intervention end.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Cory L. Christiansen, PhD, Rocky Mountain Regional VA Medical Center, Aurora, CO
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Kline PW, So N, Fields T, Juarez-Colunga E, Christiansen CL. Error-Manipulation Gait Training for Veterans With Nontraumatic Lower Limb Amputation: A Randomized Controlled Trial Protocol. Phys Ther. 2021 Nov 1;101(11):pzab192. doi: 10.1093/ptj/pzab192.
- B Aledi L, Flumignan CD, Trevisani VF, Miranda F Jr. Interventions for motor rehabilitation in people with transtibial amputation due to peripheral arterial disease or diabetes. Cochrane Database Syst Rev. 2023 Jun 5;6(6):CD013711. doi: 10.1002/14651858.CD013711.pub2.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 9, 2019
Primary Completion (Estimated)
October 31, 2026
Study Completion (Estimated)
October 31, 2026
Study Registration Dates
First Submitted
June 20, 2019
First Submitted That Met QC Criteria
June 20, 2019
First Posted (Actual)
June 21, 2019
Study Record Updates
Last Update Posted (Actual)
April 13, 2026
Last Update Submitted That Met QC Criteria
April 6, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- A3237-R
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Participant data will be made available at time of study completion, per VA recommendations and approval.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes Mellitus
-
Guang NingRecruitingType 2 Diabetes Mellitus | Type1 Diabetes Mellitus | Monogenetic Diabetes | Pancreatogenic Diabetes | Drug-Induced Diabetes Mellitus | Other Forms of Diabetes MellitusChina
-
University of Colorado, DenverMassachusetts General Hospital; Beta Bionics, Inc.CompletedDiabetes Mellitus, Type 1 | Type 1 Diabetes | Diabetes type1 | Type 1 Diabetes Mellitus | Autoimmune Diabetes | Diabetes Mellitus, Insulin-Dependent | Juvenile-Onset Diabetes | Diabetes, Autoimmune | Insulin-Dependent Diabetes Mellitus 1 | Diabetes Mellitus, Insulin-Dependent, 1 | Diabetes Mellitus, Brittle | Diabetes Mellitus, Juvenile-Onset and other conditionsUnited States
-
Meir Medical CenterCompletedDiabetes Mellitus Type 2 | Diabetes Mellitus, Non-insulin Dependant | Diabetes Mellitus, on Oral Hypoglycemic Treatment | Adult Type Diabetes MellitusIsrael
-
Peking Union Medical College HospitalUnknownType 2 Diabetes Mellitus | Type 1 Diabetes Mellitus | Gestational Diabetes Mellitus | Pancreatogenic Diabetes Mellitus | Pregestational Diabetes Mellitus | Diabetes Patients in Perioperative PeriodChina
-
State University of New York at BuffaloMedical University of South Carolina; National Institute of Diabetes and Digestive...CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
State University of New York at BuffaloNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus, Type II | Diabetes Mellitus, Adult-Onset | Diabetes Mellitus, Non-Insulin-Dependent | Diabetes Mellitus, Noninsulin DependentUnited States
-
State University of New York at BuffaloMedical University of South CarolinaCompletedDiabetes Mellitus | Type 2 Diabetes Mellitus | Adult-Onset Diabetes Mellitus | Non-Insulin-Dependent Diabetes Mellitus | Noninsulin Dependent Diabetes Mellitus, Type IIUnited States
-
Hanmi Pharmaceutical Company LimitedUnknownType2 Diabetes Mellitus | Type1 Diabetes MellitusUnited States
-
Leiden University Medical CenterAndaluz Health ServiceCompletedDiabetes Mellitus | Health Behavior | Self Efficacy | Type2 Diabetes Mellitus | Type1 Diabetes MellitusNetherlands, Spain
-
Medtronic MiniMed, Inc.RecruitingType 2 Diabetes Mellitus | Type 1 Diabetes MellitusUnited States, Australia, New Zealand
Clinical Trials on Error-augmentation gait training
-
Shirley Ryan AbilityLabU.S. Department of EducationCompleted
-
McGill UniversityCanadian Institutes of Health Research (CIHR); Centre for Interdisciplinary... and other collaboratorsRecruitingCognitive Impairment | Stroke, Ischemic | Stroke HemorrhagicCanada
-
Medical University of South CarolinaCompletedStroke | Stroke, Ischemic | Stroke, AcuteUnited States
-
VA Office of Research and DevelopmentCompleted
-
Stanford UniversityThe University of Texas Health Science Center, Houston; University of California... and other collaboratorsCompletedLearning | Adaptive Expertise | Error Management TrainingUnited States
-
Universitaire Ziekenhuizen KU LeuvenKU Leuven; Bioxtreme Ltd.Completed
-
Rigshospitalet, DenmarkCompletedSimulation-based Ultrasound Training, Error-management Training, Training With Errors, Skills TransferDenmark
-
Shirley Ryan AbilityLabEnrolling by invitationStroke | Healthy | Stroke, AcuteUnited States
-
Gaziler Physical Medicine and Rehabilitation Education...RecruitingStroke | Balance | Gait Training | Walking ImpairmentTurkey (Türkiye)
-
Copenhagen Academy for Medical Education and SimulationCompletedSimulation Based Medical EducationDenmark